Phase 5 of the Cancer Gene Index Project Begins



Loading...

By Allison Proffitt

June 25, 2008 | Sophic has announced $1.3 million of funding from the National Cancer Institute to complete the Cancer Gene Index Project over the next 12 months. Sophic started the project in June 2004 with the goal of mining 8.8 million Medline abstracts to identify suspected cancer genes and manually annotate gene-disease and gene-compound relationships. So far 4,658 cancer genes have been made publically available on the NCI website.

“We’ve completed four years of work and this phase is the completion phase, which means we will have completely analyzed and annotated the 6,610 identified cancer genes with manual annotations for role codes and evidence codes,” Patrick Blake, Sophic’s CEO told Bio-IT World. “I just attended the caBIG conference and they are identifying this dataset as the backbone for cancer research across the cancer community. We’re proud and we’re thrilled to be able to offer this asset to people who are fighting this terrible disease.”

The fifth phase of the project, announced on Monday, will bring the total number of cancer related genes indexed to 6,610. Sophic has completed the work in conjunction with NCI and Biomax Informatics AG of Munich, Germany in what Blake calls “a true collaboration” using Biomax’ BioLT literature mining tool. “We developed a ‘factory assembly line’ methodology that allows the automated text mining results to be fed into the scientific team who curate and annotate the information in an efficient, quality-controlled, work-flow process,” said Klaus Heumann, CEO of Biomax. The phase-based strategy has been designed so that “nothing is missed” and that all cancer genes, cancer types, and compounds and treatments related to cancer genes are examined.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

oracle_RDC
Remote Data Capture:Acquisition and Analysis
Sponsored by Oracle

See why Electronic Data Capture (EDC) is gaining traction in the pharmaceutical
clinical trials arena. Today approximately half of all clinical trials are conducted
electronically, and the figure is rapidly rising. Report includes contributions from
Oracle Health Sciences, Pfizer, PPD, and C3i.

 



oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.



pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.



Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Web Symposia
Loading...

Bio-IT World proudly presents the Bio-IT World Web Symposia Series!

Covering a broad array of topics within the life sciences and drug development industries, these complimentary 90-minute web symposiums provide an interactive platform to learn more about cutting-edge bio-IT topics through expert analysis and discussions.

Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
Recorded on August 3, 2010
Sponsored by: Pegasystems
Program Details | Access Recording 

Next Gen Data Management for Next Gen Life Sciences
September 8, 2010 | 1:00pm - 2:30pm EST
Sponsored by Quantum
Program Details | Register Today 

 


Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.